183 related articles for article (PubMed ID: 38509729)
41. Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice.
Mishra M; Muthuramu I; Aboumsallem JP; Kempen H; De Geest B
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380754
[TBL] [Abstract][Full Text] [Related]
42. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
43. Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction.
Konstantinou DM; Chatzizisis YS; Giannoglou GD
Pharmacol Ther; 2013 Nov; 140(2):156-66. PubMed ID: 23792088
[TBL] [Abstract][Full Text] [Related]
44. Liensinine improves AngII-induced vascular remodeling via MAPK/TGF-β1/Smad2/3 signaling.
Jia P; Chen D; Zhu Y; Wang M; Zeng J; Zhang L; Cai Q; Lian D; Zhao C; Xu Y; Chu J; Lin S; Peng J; Lin W
J Ethnopharmacol; 2023 Dec; 317():116768. PubMed ID: 37308031
[TBL] [Abstract][Full Text] [Related]
45. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
[TBL] [Abstract][Full Text] [Related]
47. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
Brandt MM; Nguyen ITN; Krebber MM; van de Wouw J; Mokry M; Cramer MJ; Duncker DJ; Verhaar MC; Joles JA; Cheng C
J Cell Mol Med; 2019 Oct; 23(10):6666-6678. PubMed ID: 31368189
[TBL] [Abstract][Full Text] [Related]
48. Effect of the peptides Relaxin, Neuregulin, Ghrelin and Glucagon-like peptide-1, on cardiomyocyte factors involved in the molecular mechanisms leading to diastolic dysfunction and/or heart failure with preserved ejection fraction.
Warbrick I; Rabkin SW
Peptides; 2019 Jan; 111():33-41. PubMed ID: 29807087
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
Tamaki S; Mano T; Sakata Y; Ohtani T; Takeda Y; Kamimura D; Omori Y; Tsukamoto Y; Ikeya Y; Kawai M; Kumanogoh A; Hagihara K; Ishii R; Higashimori M; Kaneko M; Hasuwa H; Miwa T; Yamamoto K; Komuro I
PLoS One; 2013; 8(7):e68893. PubMed ID: 23894370
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
51. Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
D'Assante R; Arcopinto M; Rengo G; Salzano A; Walser M; Gambino G; Monti MG; Bencivenga L; Marra AM; Åberg DN; De Vincentiis C; Ballotta A; Bossone E; Isgaard J; Cittadini A
ESC Heart Fail; 2021 Apr; 8(2):1681-1686. PubMed ID: 33512777
[TBL] [Abstract][Full Text] [Related]
52. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
[TBL] [Abstract][Full Text] [Related]
53. Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
Bielecka-Dabrowa A; Sakowicz A; Misztal M; von Haehling S; Ahmed A; Pietrucha T; Rysz J; Banach M
Int J Cardiol; 2016 Oct; 221():1073-80. PubMed ID: 27448535
[TBL] [Abstract][Full Text] [Related]
54. SGK1 is necessary to FoxO3a negative regulation, oxidative stress and cardiac fibroblast activation induced by TGF-β1.
González-Herrera F; Catalán M; Anfossi R; Maya JD; Pedrozo Z; Díaz-Araya G; Vivar R
Cell Signal; 2023 Sep; 109():110778. PubMed ID: 37343898
[TBL] [Abstract][Full Text] [Related]
55. The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.
Morales MG; Abrigo J; Meneses C; Simon F; Cisternas F; Rivera JC; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2014 Aug; 127(4):251-64. PubMed ID: 24588264
[TBL] [Abstract][Full Text] [Related]
56. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
[TBL] [Abstract][Full Text] [Related]
57. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
Gu LY; Yun-Sun ; Tang HT; Xu ZX
J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
[TBL] [Abstract][Full Text] [Related]
58. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
Li X; Zhang ZL; Wang HF
Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
[TBL] [Abstract][Full Text] [Related]
59. Early Passive Leg Movement Prevents Against the Development of Heart Failure With Preserved Ejection Fraction in Rats.
Liu J; Ji XX; Fu Y; Zhang WC; Ji HF; Liu JW; Cheng XS; Dong YF
Front Cardiovasc Med; 2021; 8():655009. PubMed ID: 33969019
[TBL] [Abstract][Full Text] [Related]
60. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
